Educational Resources

Poster ASMS 2025: Evaluating GMet’s FIA for High-Impact Metabolomics

In a modern research environment using multi-omics, the ability to collect metabalomic data at the same scale and speed as genomics is key. This poster, originally presented at ASMS 2025, makes a head-to-head comparison of GMet's FIA platform on an Agilent 6550 Q-TOF vs LC-MS on a Sciex X500 QTOF, showcasing GMet's FIA performance and applicability as a robust platform for scalable, untargeted metabalomics.

Application Spotlight: ULLAND ET AL. 2017

Alzheimer’s Disease is a debilitating neurodegenerative illness for which there are currently no effective treatments. Mutations in the AD-associated gene TREM2 have been implicated in dysregulated microglial autophagy – the degradation of intracellular structures in immune cells that regulate homeostasis in the central nervous system.

Application Spotlight: FU ET AL. 2020

Dana Farber Researchers use Untargeted Metabolomics to Identify New Metabolic Mechanisms in Pancreatic Cells Diabetes is an incurable metabolic disease that affects over 500 million people.